Diplomat Pharmacy Raises $173M In IPO, Below Expectations
Specialty drugmaker Diplomat Pharmacy on Thursday said it has raised $173 in its initial public offering on the New York Stock Exchange, with shares priced at $13 apiece, below the target...To view the full article, register now.
Already a subscriber? Click here to view full article